Prognostic implication of BRAF and TERT promoter mutation combination in papillary thyroid carcinoma-A meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prognostic implication of BRAF and TERT promoter mutation combination in papillary thyroid carcinoma-A meta-analysis

Published:2017-08-02 Issue:5 Volume:87 Page:411-417
ISSN:0300-0664
Container-title:Clinical Endocrinology
language:en
Short-container-title:Clin Endocrinol

Author:

Vuong Huy Gia¹,Altibi Ahmed M.A.²^ORCID,Duong Uyen N.P.³,Hassell Lewis⁴

Affiliation:

1. Department of Pathology; Cho Ray Hospital; Ho Chi Minh City Vietnam

2. Faculty of Medicine; University of Jordan; Amman Jordan

3. Pham Ngoc Thach University of Medicine; Ho Chi Minh City Vietnam

4. Department of Pathology; University of Oklahoma Health Sciences Center; Oklahoma City OK USA

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Endocrinology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cen.13413/fullpdf

Reference29 articles.

1. Current thyroid cancer trends in the United States;Davies;JAMA Otolaryngol Head Neck Surg,2014

2. Pathology and genetics of thyroid carcinoma;DeLellis;J Surg Oncol,2006

3. Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer;Xing;JAMA,2013

4. TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas;Melo;J Clin Endocrinol Metab,2014

5. Highly prevalent TERT promoter mutations in aggressive thyroid cancers;Liu;Endocr Relat Cancer,2013

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TERT promoter mutations and additional molecular alterations in thyroid fine-needle aspiration specimens: A multi-institutional study with histopathologic follow-up;American Journal of Clinical Pathology;2024-09-09

2. Treatment of Unresectable BRAF V600E, TERT-Mutated Differentiated Papillary Thyroid Cancer With Dabrafenib and Trametinib;JCEM Case Reports;2024-07-24

3. The Long Journey towards Personalized Targeted Therapy in Poorly Differentiated Thyroid Carcinoma (PDTC): A Case Report and Systematic Review;Journal of Personalized Medicine;2024-06-18

4. Aggressive value of preoperative multi-genic assay and implications for initial surgical management in papillary thyroid cancer;2024-06-17

5. The role of the ThyGeNEXT oncogene panel used in combination with the expanded miRNA panel ThyraMIRv2 in Indeterminate thyroid nodules: A large, blinded, real‐world, observational study;Cancer Cytopathology;2024-05-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3